Aclarion Files 8-K on Operations, Financial Condition, and Warrants
Ticker: ACONW · Form: 8-K · Filed: Feb 21, 2024 · CIK: 1635077
| Field | Detail |
|---|---|
| Company | Aclarion, INC. (ACONW) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, regulation-fd, corporate-governance
TL;DR
**Aclarion just dropped an 8-K on its financials and warrants, keep an eye on their operational health.**
AI Summary
Aclarion, Inc. filed an 8-K on February 21, 2024, reporting on its results of operations and financial condition, along with a Regulation FD Disclosure. The filing indicates that the company's common stock has a par value of $0.00001 per share and also mentions warrants exercisable for one share of common stock. This report was filed under SEC File Number 001-41358.
Why It Matters
This filing provides an update on Aclarion's financial health and operational status, which is crucial for investors to assess the company's ongoing viability and future prospects.
Risk Assessment
Risk Level: medium — The filing mentions financial condition and operations but lacks specific details, which could indicate undisclosed issues or significant changes.
Key Numbers
- $0.00001 — Common Stock Par Value (per share)
Key Players & Entities
- Aclarion, Inc. (company) — registrant
- $0.00001 (dollar_amount) — par value per share of common stock
- February 21, 2024 (date) — date of earliest event reported and filing date
- Delaware (company) — state of incorporation
- 001-41358 (company) — SEC File Number
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 21, 2024.
What is the par value of Aclarion, Inc.'s common stock?
The par value of Aclarion, Inc.'s common stock is $0.00001 per share.
What items of information were included in this 8-K filing?
The 8-K filing included information on Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits.
What is Aclarion, Inc.'s SEC File Number?
Aclarion, Inc.'s SEC File Number is 001-41358.
Does this filing mention any outstanding warrants?
Yes, the filing mentions warrants, each exercisable for one share of common stock.
Filing Stats: 561 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-02-21 17:25:43
Filing Documents
- aclarion_8k.htm (8-K) — 34KB
- aclarion_ex9901.htm (EX-99.1) — 518KB
- 0001683168-24-001102.txt ( ) — 825KB
- acon-20240221.xsd (EX-101.SCH) — 4KB
- acon-20240221_def.xml (EX-101.DEF) — 26KB
- acon-20240221_lab.xml (EX-101.LAB) — 36KB
- acon-20240221_pre.xml (EX-101.PRE) — 25KB
- aclarion_8k_htm.xml (XML) — 6KB
02
Item 2.02. Results of Operations and Financial Condition. On February 21, 2024, Aclarion, Inc. (the "Company") filed amendment no. 2 to its S-1 registration statement relating to a proposed public offering. That amendment included audited financial statements for the Company's year ended December 31, 2023 and December 31, 2022. A copy of the Company's audited financial statements for the years ended December 31, 2023 and December 31, 2022 is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
01
Item 7.01 Regulation FD Disclosure. The information set forth under Item 2.02 is incorporated by reference into this Item 7.01. The information in Items 2.02 and 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Aclarion, Inc. Audited Financial 104 Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACLARION, INC. February 21, 2024 By: /s/ John Lorbiecki Name: John Lorbiecki Title: Chief Financial Officer 3